Project facts
EDCMET is co-funded by the Horizon 2020 programme of the European Union.
- Acronym: EDCMET
- Full title: Metabolic effects of Endocrine Disrupting Chemicals: novel testing METhods and adverse outcome pathways
- Programme: 2020-EU.3.1.1. Undestanding Health, wellbeing and disease
- Topic: SC1-BHC-27_2018 New testing and screening methods to identify endocrine disrupting chemicals
- Call: H2020-SC1-2018-Single-Stage-RTD
- Grant Agreement number: 825762
- Duration: 1 January 2019 – 30 June 2024
- Budget: 5 980 408,75 €
- Coordinator: University of Eastern Finland, Professor Anna-Liisa Levonen
- External Scientific Advisory Board:
Olavi Pelkonen, University of Oulu
Nico P.E. Vermeulen, Vrije Universiteit
Anne Marie Vinggaard, Technical University of Denmark
Philip Marx-Stoalting, German Federal Institute for Risk Assessment
EDCMET flyer (flyer in pdf format)

EDCMET project poster (poster in pdf format)


the European Union’s Horizon 2020
research and innovation programme
under grant agreement No 825762.